Related Experiment Video
Updated: Jun 13, 2025
08:57
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
27.0K
Demyelination and Remyelination: General Principles.
Jianqin Niu1,2, Alexei Verkhratsky3,4,5,6,7,8, Arthur Butt9
1Department of Histology and Embryology, Third Military Medical University, Chongqing, China. jianqinniu@tmmu.edu.cn.
Advances in Neurobiology
|June 11, 2025
Summary
Oligodendrocytes, crucial for central nervous system health, are implicated in all neurological diseases. Understanding demyelination and remyelination is key to developing treatments for myelin disorders.
Area of Science:
- Neuroscience
- Cell Biology
- Neuropathology
Background:
- Oligodendrocytes and oligodendrocyte precursor cells (OPCs) are vital CNS cells implicated in neurological diseases.
- Oligodendroglial pathology involves myelin disruption (demyelination) and repair (remyelination), central to white matter diseases like multiple sclerosis and other neuropathologies.
- Factors such as neuroinflammation, oxidative stress, and excitotoxicity drive oligodendroglial changes.
Purpose of the Study:
- To summarize key features of demyelination and remyelination.
- To discuss factors contributing to remyelination failure.
- To compare human and mouse differences in oligodendroglial pathology and propose treatment strategies.
Main Methods:
- Literature review and synthesis of existing research on demyelination and remyelination.
- Comparative analysis of human and mouse models of demyelinating diseases.
- Exploration of therapeutic strategies for promoting remyelination.
Main Results:
- Demyelination is myelin loss, while remyelination is myelin repair by OPCs.
- Remyelination failure can be influenced by various pathological factors.
- Differences exist between human and mouse responses to demyelinating conditions.
Conclusions:
- Understanding demyelination and remyelination pathogenesis is crucial for developing effective therapies.
- Addressing remyelination failure requires a comprehensive approach considering cellular and molecular mechanisms.
- Future research and therapeutic strategies should consider species-specific differences for optimal treatment of demyelinating diseases.
Related Concept Videos
01:25Nervous Tissue: Myelin
2.4K
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
2.4K
01:15Neurogenesis and Regeneration of Nervous Tissue
739
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
739